---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-093898"
form_type: "8-K"
ticker: null
cik: "0001839998"
company_name: "American Oncology Network, Inc."
filed_at: "2023-08-21T23:59:59+00:00"
generated_at: "2026-06-11T06:29:25.347534+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Digital Transformation Opportunities extends deadline for business combination to Sept 30, 2023

## Summary
- Sponsor deposited $50,000 into trust to extend deadline from Aug 31, 2023 to Sep 30, 2023.
- Extension funded by a non-interest-bearing promissory note due at business combination or liquidation.
- Prior extension had moved deadline from July 31 to Aug 31, 2023.

## SEC filing metadata
- accession: 0001104659-23-093898
- form_type: 8-K
- cik: 0001839998
- company_name: American Oncology Network, Inc.
- filed_at: 2023-08-21T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1839998/000110465923093898/0001104659-23-093898-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1839998/000110465923093898/tm2324279d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-093898
- JSON: https://secwatch.observer/filing/0001104659-23-093898.json
- Plain text: https://secwatch.observer/filing/0001104659-23-093898.txt

## Key facts
- Debt Financings
  American Oncology Network, Inc. incurred loan of $50,000 with Digital Transformation Sponsor LLC at non-interest bearing maturing upon the earlier of (i) the date of the consummation of the Company’s initial business combination and (ii) the date of the liquidation of the Company.
  - Instrument: loan
  - Principal: $50,000
  - Counterparty: Digital Transformation Sponsor LLC
  - Rate: non-interest bearing
  - Maturity: upon the earlier of (i) the date of the consummation of the Company’s initial business combination and (ii) the date of the liquidation of the Company
  - Event: incurrence
  source text: the Company is required to complete its initial business combination from August 31, 2023 to September 30, 2023. In accordance with the Company’s charter, the Sponsor deposited $50,000 into the trust account established for the benefit of the Company’s public stockholders, which was evidenced by a non-interest bearing, unsecured promissory note issued in favor
  evidence_url: https://www.sec.gov/Archives/edgar/data/1839998/000110465923093898/0001104659-23-093898-index.htm
- Material Agreements
  American Oncology Network, Inc. entered into Extension Note with Digital Transformation Sponsor LLC valued at $50,000 (effective 2023-08-21).
  - Action: entry
  - Counterparty: Digital Transformation Sponsor LLC
  - Value: $50,000
  - Effective: 2023-08-21
  source text: On August 21, 2023, Digital Transformation Sponsor LLC (the “Sponsor”) delivered written notice to Digital Transformation Opportunities Corp. (the “Company”), regarding its exercise of the option to extend the date by which the Company is required to complete its initial business combination from August 31, 2023 to September 30, 2023. In accordance with the Company’s charter, the Sponsor deposited $50,000 into the trust account established for the benefit of the Company’s public stockholders, which was evidenced by a non-interest bearing, unsecured promissory note issued in favor of the Sponsor (the “Extension Note”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1839998/000110465923093898/0001104659-23-093898-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.